Tandem Diabetes Care Files For IPO

San Diego-based Tandem Diabetes Care, a medical device manufacturer which makes touchscreen-enabled insulin pumps, has filed for an IPO. Tandem said it is looking to raise up to $100.0M in an IPO on the NASDAQ Global Market, trading as TNDM. The firm's IPO is being underwritten by BofA Merrill Lynch, Piper Jaffray, Deutsche Bank Securities, and Stifel. Tandem Diabetes Care is venture backed by Delphi Ventures, Domain Associates, TPG Biotechnology, HLM Venture Partners, Kearny Venture Partners, as well as others.